SEC Form D · filed September 9, 2016
Adgero Biopharmaceuticals Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Frank P. Pilkiewicz · Princeton, NJExec · DirectorDavid P. Hochman · Princeton, NJDirectorTim P. Mcinerney · Princeton, NJDirectorAllen P. Bloom · Princeton, NJDirectorSteve P. Rychnovsky · Princeton, NJExecRoman P. Perez-Soler · Princeton, NJDirectorRagan Young · Dallas, TXExec · DirectorDavid Dunn · Wilton, CTDirectorRobert A. Granieri · New York, NYDirectorNicolai Wadstrom · San Francisco, CADirectorMichael A. Jenkins · New York, NYDirectorHelen L. Francis · Westport, CTExecLinzy O. Scott · Atlanta, GADirectorLindsay Watson · Hamilton, BermudaDirectorMark Way · Hamilton, BermudaExec · DirectorAlastair Barbour · Edinburgh, United KingdomDirectorCarrie M. Bass · Dallas, TXDirectorRobert B. Knapp · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗